Advice
Following an abbreviated submission
Atorvastatin calcium (Lipitor) is accepted for restricted use in the NHS in Scotland as an adjunct to diet for the reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in children aged 10 years and older with primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia when response to diet and other non-pharmacological measures is inadequate.
It is restricted to initiation by paediatricians or physicians specialising in the management of lipid disorders.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Atorvastatin (Lipitor®)
- SMC ID:
- 202/05
- Indication:
- Reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in children aged 10 years and older with primary hypercholesterolaemia, heterozygous familial hypercholeste
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 10 October 2005